Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Lymphoma 58Multiple Myeloma 52Leukemia 48Leukemia, Myeloid, Acute 44Precursor Cell Lymphoblastic Leukemia-Lymphoma 41Myelodysplastic Syndromes 37Lymphoma, Non-Hodgkin 37Hodgkin Disease 36Lymphoma, Mantle-Cell 26Lymphoma, Large B-Cell, Diffuse 26Leukemia, Lymphocytic, Chronic, B-Cell 25Lymphoma, Follicular 22Breast Neoplasms 22Burkitt Lymphoma 21Lymphoma, B-Cell, Marginal Zone 16Congenital Abnormalities 15Lymphoma, Large-Cell, Immunoblastic 14Recurrence 13Leukemia, Myelogenous, Chronic, BCR-ABL Positive 13Sarcoma 12Neoplasms, Plasma Cell 12Hematologic Neoplasms 10Leukemia, Myelomonocytic, Juvenile 9Leukemia, Biphenotypic, Acute 9Blast Crisis 9Neoplasms 8Myeloproliferative Disorders 8Leukemia, Myelomonocytic, Chronic 8Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7Neuroblastoma 7

Interventions

Cisplatin 32human papillomavirus vaccine, L1 type 16, 18 16Brachytherapy 15Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 12Paclitaxel 11Bevacizumab 11pembrolizumab 10Platinum 91,2-diaminocyclohexaneplatinum II citrate 9Topotecan 8Radiotherapy, Intensity-Modulated 8Radiation 8Papillomavirus Vaccines 8atezolizumab 6Gemcitabine 6Fluorodeoxyglucose F18 6Cyclophosphamide 6tisotumab vedotin 5fludarabine phosphate 5fludarabine 5aldesleukin 5Taxes 5Radiotherapy 5Magnetic Resonance Spectroscopy 5Carboplatin 5Vaccines, Synthetic 4Nivolumab 4Immunoglobulin G 4Disulfides 4Colposcopy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Uterine Cervical Neoplasms × Filgrastim × Clear all
NCT04514692 2025-04-23

Bone Marrow Sparing Image-Guided Radiation Therapy (RT) Incorporating Novel Use of GCSF and FDG-PET Imaging

Stanford University

Phase 1/2 Terminated
7 enrolled 9 charts
Gynecologic

Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT01266447 2019-08-08

Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer

National Cancer Institute (NCI)

Phase 2 Completed
27 enrolled 11 charts
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡